Abstract. Astragaloside is one of the most common traditional Chinese medicines and is derived from Astragalus membranaceus.
Introduction
Reperfusion is the most effective method of limiting acute myocardial ischemia necrosis. However, reperfusion may also be associated with a burst of reactive oxygen species (ROS) production and intracellular calcium overload (1) (2) (3) . These dichotic effects result in paradoxical cardiocyte dysfunction, a phenomenon termed myocardial ischemia reperfusion injury (MIRI). The role of mitochondria during MIRI is critical, as apoptosis is promoted by the mitochondrial pathway associated with the mitochondrial permeability transition (MPT). MPT pores (MPTPs) are located in the inner mitochondrial membrane, and when MIRI induces cellular dysfunction, including increased Ca 2+ concentrations and oxidative stress, mitochondria undergo swelling and become uncoupled due to the opening of MPTPs (4) . This leads to matrix swelling, release of apoptotic signaling molecules and irreversible injury to the mitochondria (5) . The role of the mitoK ATP channel in modulating cardiac mitochondrial function has been investigated previously (6,7). Wakiyama et al (8) confirmed that the opening of mitochondrial adenosine triphosphate-sensitive potassium channels (mitoK ATPs ) may reduce the release of cytochrome c, inhibit caspase-3 activation, stabilize the mitochondrial membrane potential (MMP) and inhibit apoptosis (8) .
Astragaloside is one of the most common Traditional Chinese Medicines. It possesses multiple physiological and pharmacological functions, including a protective effect in the myocardium following ischemic injury. This effect may be associated with clearing oxygen free radicals or reducing blood viscosity (9, 10) . Notably, prior work has demonstrated that Astragalus injection (Huangqizhusheye) may activate the mitoK ATPs and reduce MIRI (11) . Astragaloside IV (AsIV) is an extract of the monomer astragaloside (Fig. 1) . AsIV produces various effects, including protection against cerebral ischemia-reperfusion injury, and the attenuation of renal tubulointerstitial fibrosis and diabetes (12) (13) (14) . Certain Effect of astragaloside IV against rat myocardial cell apoptosis induced by oxidative stress via mitochondrial ATP-sensitive potassium channels protective effects of AsIV on cardiovascular disease have also been suggested (15) (16) (17) (18) (19) . In addition to providing cardioprotection during myocardial ischemia (18, 19) , AsIV has also been demonstrated to limit endothelial dysfunction induced by oxidative stress (15) and inhibit compensatory hypertrophy of myocardial cells (16) . The results obtained in these previous studies provided the impetus to study the mechanism of AsIV protection during reperfusion.
In the current study, the protective role of mitoK ATPs following AsIV treatment was investigated in cardiocytes. Oxidative stress in cardiocytes was stimulated by treating cultured cells with 0.2 mmol/l hydrogen peroxide (H 2 O 2 ) (20) , resulting in calcium overload and damage to the MMP. These three factors may act separately, or interact with each other to cause damage to cellular structure, function and metabolism, and ultimately result in cell death. This type of injury simulates the pathogenesis of MIRI; thus, the present study used this model to analyze the effect of AsIV on MIRI and its underlying mechanisms.
Materials and methods
Cell culture and reagents. Primary rat neonatal cardiocytes were derived from 1-2-day-old Wistar rats (Experimental Animal Holding Facility of Jilin University, China). Briefly, the hearts were removed under aseptic conditions and the ventricles were homogenized in D-Hank's buffer. The tissue fragments were digested by stepwise exposure to 0.125% pancreatin (Gibco Life Technologies, Carlsbad, CA, USA). The dissociated cells were pre-plated for 90 min to remove fibroblasts, and the non-adherent cardiocytes were then plated at a density of 1x10 5 cells/mm 2 . Cells were cultured in Iscove's modified Dulbecco's medium supplemented with 10% fetal bovine serum and 1% penicillin/streptomycin (BHKT Clinical Reagent Co., Ltd, Beijing, China), and maintained at 37˚C in an incubator with 95% O 2 and 5% CO 2 . All animal studies were performed in accordance with the Guide for the Care and Use of Laboratory Animals and approved by the Institutional Animal Care and Use Committee of Jilin University (Changchun, China). Cardiocyte viability and lactate dehydrogenase (LDH) activity. Cardiocyte survival was assessed using an MTT assay. Briefly, cells were incubated with 200 µl medium in 96-well plates, 5 µl MTT stock solution (5 mg/ml) was then added to each well and the cells were incubated for a further 4 h. Blue formazan precipitate was produced from the cells by adding 100 µl DMSO and gently shaking, and the absorbance was measured at 570 nm using an A-5082 ELISA reader (Chengdu Taimeng Technology Co., Ltd., Chengdu, China). LDH release was measured using a GF-200 Semi Automatic Biochemical Analyzer (Shandong Gaomi Caihong Instruments Co., Ltd., Gaomi, China).
Analysis of ROS production. Intracellular ROS levels were analyzed using a flow cytometer with DCFH staining. DCFH was dissolved in ethanol (Beijing Chemical Factory, Beijing, China) to produce a 1 mmol/l stock solution. Cells were subsequently washed three times with phosphate-buffered saline (PBS) prior to the addition of DCFH (10 µM). Following a 10-min incubation in the dark, the cells were washed three times then resuspended in PBS. Fluorescence was measured using a fluorescence microplate reader at 488/525 nm (Gemini XPS; Shanghai Spectrum Instruments Co., Ltd., Shanghai, China).
Apoptosis analysis. The non-adherent myocytes were digested by treatment with 0.25% pancreatin for 10 min. The cells were then washed twice with PBS, and the percentage of apoptotic cells was determined with an Coulter Epics XL flow cytometer (Beckman Coulter, Brea, CA, USA) after double staining with the Annexin V-FITC apoptosis detection kit (Tianjin Sungene Biotech Co., Ltd. China). Annexin V was used as an apoptosis indicator and propidium iodide (PI) as a necrosis indicator. An + PI -represents viable apoptotic cells in the lower right quadrant. ]i were analyzed using a Fluoview FV500 confocal laser scanning microscope (Olympus Corporation, Tokyo, Japan). Cells in 24-well plates were washed with HEPES buffer and treated with Fluo-3/AM (10 µmol/l) for 40 min in the dark. Following removal of Fluo-3/AM, the cells were washed three times with HEPES, and fresh HEPES was added with the various drug treatments as described. Baseline fluorescence in normal cells was recorded for 1 min, then H 2 O 2 was added and the change in fluorescence was measured for 5 min. The results were analyzed using software which accompanied the confocal microscope. Alterations in the levels of green fluorescence were used to evaluate [Ca 2+ ]i.
MMP (ΔΨm).
Fluorescence imaging of ΔΨm was conducted using Rhodamine 123 as an indicator. Rhodamine 123 is a mitochondria-selective dye, which in a reaction driven by ΔΨm in normal polarized mitochondria, assembles into red fluorescence-emitting dimers forming J-aggregates. Changes in MMP were analyzed using the confocal microscope. Cells in 24-well plates were treated with Rhodamine 123 (5 µg/ml) for 10 min away from light. Following removal of Rhodamine 123, the cells were washed with PBS. The level of Rhodamine 123 was measured and analyzed with the Fluoview Viewer software, version 1.7a (Olympus Corporation).
Statistics. Data are expressed as the mean ± standard error of the mean. Statistical significance was calculated using one-way analysis of variance with Newman-Keuls post hoc test. P<0.05 was considered to indicate a statistically significant difference. (Fig. 2) . As indicated in Fig. 3 
Results

Effect of AsIV
AsIV alters oxidative stress and [Ca
2+
]i. Elevated levels of ROS may contribute to ischemia-reperfusion injury. Therefore, the present study evaluated whether AsIV-mediated cardioprotection may be partially attributed to a reduction in oxidative stress. ROS generation was assessed by DCFH fluorescence. The results indicated that H 2 O 2 induced significant ROS generation in cardiocytes compared with the DMSO control group (P<0.01) (Fig. 3) , which was reduced following AsIV treatment (P<0.05 vs. the H 2 O 2 group). This protective effect was significantly attenuated by 5-HD pretreatment (P<0.05). These results indicate that AsIV may protect cardiocytes against H 2 O 2 injury by reducing oxidative stress; and this effect may be associated with the mitoK ATP . Ca 2+ overload is a key contributor to the mitochondrial permeability transition leading to ischemia-reperfusion injury. As displayed in Fig. 4 , AsIV-pretreated cells presented significantly lower [Ca 2+ ]i compared with that of the H 2 O 2 group (P<0.01). 5-HD pretreatment prior to AsIV exposure resulted in significantly higher [Ca 2+ ]i compared with that of the AsIV group (P<0.01). These results indicated that AsIV may relieve Ca 2+ overload, an effect which is also associated with the mitoK ATP .
Changes in MMP.
MPTP opening may be critical for the transition from reversible to irreversible myocardial ischemia-reperfusion injury. Therefore, the present study investigated MPTP dynamics in cardiocytes using Rhodamine 123. The MMP was (93.80±19.53) 30 min subsequent to AsIV treatment, which was significantly higher than that in the H 2 O 2 group (P<0.01) (Fig. 5) . 5-HD pretreatment prior to AsIV led to an MMP that was significantly lower than that of the AsIV group (P<0.01). These results demonstrated that AsIV may protect cardiocytes by stabilizing the MMP, and this effect may be associated with the mitoK ATP .
Changes in the rate of apoptosis. The effect of AsIV on cell apoptosis was analyzed by measuring Annexin V positivity using flow cytometry. Pretreatment with AsIV led to significantly reduced Annexin V-positivity compared with the H 2 group (P<0.01). By contrast, pretreatment with 5-HD resulted in a significant increase in the number of Annexin V-positive cells compared with the AsIV group (P<0.01) (Fig. 6) . These results demonstrated that AsIV treatment may reduce apoptosis, and this may be associated with the mitoK ATP .
Discussion
The generation of ROS leads to damage to the cellular membrane, and is able to evoke calcium overload by raising membrane permeability, resulting in an inflow of calcium ions. Calcium overload may activate calcium-dependent proteinase, which catalyzes the conversion of xanthine dehydrogenase to xanthine oxidase (XO). XO promotes xanthine decomposition into uric acid with concomitant excess oxygen free radical generation. Mitochondrial Ca 2+ overload, coupled with a high intracytoplasmic ROS burden, promotes the opening of the MPTPs, which induces the release of calcium from mitochondria resulting in mitochondrial swelling or failure. The combination of increased ROS, Ca 2+ overload and mitochondrial injury is a notable cause of cardiocyte apoptosis.
The results of the current study demonstrated that AsIV increased cardiocyte viability and reduced LDH release. Additionally, pretreatment with AsIV significantly reduced apoptosis, which demonstrated that AsIV was able to protect cardiocytes from H 2 O 2 injury and inhibit apoptosis.
AsIV-mediated attenuation of ROS generation and Ca
2+
overload in H 2 O 2 -damaged cardiocytes demonstrated that A B the protective effects of AsIV are dependent on antioxidant activity and reducing the intracellular calcium overload. These effects may protect cardiocytes by attenuating damage to mitochondrial function.
Mitochondrial activity is required for efficient function of the cardiovascular system. In response to cardiovascular injury, mitochondrial dysfunction may result in apoptosis and necrosis (21) . A change in mitochondrial permeability is considered the primary event in the cell apoptosis cascade (22) (23) (24) . The fluctuations in MMP result in cytochrome c release, which can initiate caspase-9 and -3 activation, and subsequent apoptosis (25) . In the present study, AsIV was observed to protect against cell death by modulating mitochondrial membrane permeability, which may attenuate the release of cytochrome c and reduce cardiocyte apoptosis. MitoK ATP channels are located in the mitochondrial inner membrane, and the opening of these channels has been suggested to be protective against excessive mitochondrial Ca 2+ accumulation, as mitoK ATP opening leads to depolarization, which reduces the driving force responsible for mitochondrial Ca 2+ uptake (26) . MitoK ATP opening also regulates ROS generation; in early ischemia (30 min), mitoK ATP opening can increase the production of ROS to begin cardiocyte protection by preconditioning. However, during late ischemia (24 h) or reperfusion, mitoK ATP opening may reduce the production of ROS to reduce injury (27) . Previous studies have indicated that mito-K ATP serves an important function in the protection against ischemia-reperfusion injury by the mitoK ATP opening agent, diazoxide, using an siRNA method and mitoK ATP blocker 5-HD (28, 29) . Wakiyama et al (8) confirmed that mitoK ATP opening may attenuate the release of cytochrome c, inhibit caspase-3 release, stabilize the MMP and inhibit apoptosis. Soeding et al (30) also demonstrated that levosimendan, a calcium sensitizer, preserves the contractile responsiveness of hypoxic human myocardium via mitoK ATPs and potential pERK1/2 activation.
To investigate the link between AsIV and the mitoK ATP , the present study examined the effect of 5-HD on the effects of AsIV. It was observed that pretreatment with 50 µmol/l 5-HD, (a specific mitoK ATP blocker) partially abrogated the protective effect of AsIV in the cardiocytes. 5-HD led to a reduction in viability and MMP, an increase in the levels of LDH and apoptosis and an increase in calcium overload, compared with the AsIV group. These data indicate that AsIV may protect cardiocytes from H 2 O 2 injury through activating mitoK ATP . This concentration of 5-HD had no effect on cardiocytes alone (data not shown). It was also observed that AsIV produced a similar protective effect to the drug nicorandil, a mitoK ATP activator.
Based on these findings, it was concluded that the opening of mitoK ATPs may be the principal mechanism through which AsIV protects cardiocytes from H 2 O 2 injury. AsIV may inhibit apoptosis in cardiocytes via several mechanisms: i) AsIV inhibits the initiation of apoptosis by reducing the formation 
A B
of ROS and intracellular calcium overload; ii) AsIV inhibits the opening of MPTPs, which may reduce the release of apoptosis-inducing proteins, including cytochrome c, Smac and AIF; and iii) mitoK ATP opening may facilitate the signal transduction required for protection by AsIV. Further studies are required to elucidate whether other trigger factors underlie the protective effects of AsIV. Additionally, the detailed downstream mediators of mitoK ATP require clarification.
